Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Skrit37on Aug 17, 2022 12:27pm
121 Views
Post# 34902394

RE:RE:RE:RE:RE:$90,000

RE:RE:RE:RE:RE:$90,000Well...just imo of coarse but ...a company isnt gonna wait till the last penny before asking around for more money .....so either 1) they cant find and giver of funds... 2) have found a giver of funds but is under negotiation .. 3) deffered moneys coming in ( although this is unlikely, unless its a massive sum and is trickling in 4) and is hopefully the case, they are able to sustain positive cash flow to keep the lights on Did i miss one? Your guess is as good as mine
brad129 wrote:

Ya I saw that as well, but in my opinion the cash aspect is the single simplest way to look, 

there are deferred management salaries as well, also accounts payable . Not sure on pages but it's there. I think management salaries owing climbed an additional 100k not sure if that was for the three months is 6 month period.



LithLover wrote: On page 24 there is also Deferred Revenue of $180,540. 

$97k Lab testing and $83k Care

 

brad129 wrote:

The basic math, I'm not going right through it again detail by detail.
 

They went through some like $550k from last quarter about 172k a month with only 90k left that's about 2 weeks not 6 and almost 7 weeks.

financing would be announced to close on a future date. As Tripping said 4-5 weeks away how are they paying employees, who sticks around without a pay cheque?


 

Liked2Think wrote: how did you calculate this.  

i refuse to take the time to dive into anything with this company but I am interested

After listening to the cc though didnt he mention its been a tough time to get financing due to (insert ukraine war and inflation, and defining new meanings of recession via the Biden protocol)?

Maybe the people "in charge" of this company refuse to take deals of sub 5 cent mark because like some of the pumpers here they will not accept that they have sunk this company. This just means they will end up taking a far worse deal down the road. That HC wainwright deal was just fantastic for the company.
 

 

 







<< Previous
Bullboard Posts
Next >>